A trial that compares Monsel's paste with ball electrode for hemostasis after loop electrosurgical excision procedure.
OBJECTIVE
The purpose of this study was to compare Monsel's paste with fulguration with ball electrode for hemostasis after loop electrosurgical excision procedure.


METHODS
One hundred healthy women were assigned randomly by computer-generated random numbers to ball electrode or thickened Monsel's paste for hemostasis after loop electrosurgical excision procedure. Patients rated pain during hemostasis using a visual analog scale. At 2 weeks, postprocedural vaginal discharge was rated on a Likert scale. Pathology was reviewed for dysplasia grade and margin status. Recurrent dysplasia on repeat Papanicolaou tests was noted.


RESULTS
Six patients (2 Monsel's and 4 fulguration) required an alternate method of hemostasis. Patient demographics, postprocedural discharge, and recurrent dysplasia were comparable between the 2 groups. Visual analog scale scores and hemostasis time were significantly higher in the fulguration group. Estimated blood loss, although higher in the fulguration group, was not significant between groups.


CONCLUSIONS
Monsel's paste and fulguration with ball electrode appear be equally effective as hemostatic agents after loop electrosurgical excision procedure.
Lipscomb
Gary H
GH
Division of Gynecologic Specialties, Department of Obstetrics and Gynecology, University of Tennessee Health Science Center, Memphis, TN, USA. glipscomb@utmem.edu
Roberts
Kim A
KA
Givens
Vanessa M
VM
Robbins
Dianne
D
D000328:Adult; D002584:Cervix Uteri / Q000503:physiopathology / Q000601:surgery*; D004564:Electrocoagulation / Q000295:instrumentation; D004566:Electrodes; D004867:Equipment Design; D005260:Female; D005290:Ferric Compounds / Q000627:therapeutic use*; D006489:Hemostatic Techniques / Q000295:instrumentation; D006490:Hemostatics / Q000627:therapeutic use*; D006801:Humans; D066298:In Vitro Techniques; D010147:Pain Measurement; D010149:Postoperative Pain / Q000503:physiopathology; D011182:Postoperative Care; D013431:Sulfates / Q000627:therapeutic use*; D016896:Treatment Outcome
D005290:Ferric Compounds; D006490:Hemostatics; D013431:Sulfates; C028968:ferric subsulfate solution